Select Medical Holdings Corporation (SEM) Earnings History
Annual and quarterly earnings data from 2005 to 2025
Loading earnings history...
EPS Growth Rates (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | 11.5% | 0.0% | 2.7% |
| 2024 | 12.2% | 5.2% | 4.1% |
| 2023 | 14.0% | 8.3% | 3.7% |
| 2022 | 11.6% | 6.4% | 2.5% |
| 2021 | 14.8% | 11.5% | 6.5% |
Download Data
Export SEM earnings history in CSV or JSON format
Free sign-in required to download data
Select Medical Holdings Corporation (SEM) Earnings Overview
As of February 28, 2026, Select Medical Holdings Corporation (SEM) reported trailing twelve-month net income of $110M, reflecting -0.3% year-over-year growth. The company earned $0.89 per diluted share over the past four quarters, with a net profit margin of 0.0%.
Looking at the long-term picture, SEM's 5-year EPS compound annual growth rate (CAGR) stands at -9.7%, signaling declining earnings. The company achieved its highest annual net income of $402M in fiscal 2021.
Select Medical Holdings Corporation maintains positive profitability with a gross margin of 0.1%, operating margin of 0.0%, and net margin of 0.0%. The company continues to generate positive earnings from operations. View revenue history →
Compared to industry peers including ENSG ($328M net income, 0.1% margin), EHC ($541M net income, 0.1% margin), BKD (-$263M net income, -0.1% margin), SEM has room to improve margins relative to the peer group. Compare SEM vs ENSG →
Peer Comparison
Earnings metrics vs industry competitors
Historical Data
21 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $146M | -31.7% | $2M | $1.16 | 2.7% | 0.0% |
| 2024 | $214M | -12.1% | $268M | $1.66 | 4.1% | 5.2% |
| 2023 | $243M | +53.1% | $555M | $1.91 | 3.7% | 8.3% |
| 2022 | $159M | -60.5% | $403M | $1.23 | 2.5% | 6.4% |
| 2021 | $402M | +55.3% | $714M | $2.99 | 6.5% | 11.5% |
| 2020 | $259M | +74.5% | $568M | $1.93 | 4.7% | 10.3% |
| 2019 | $148M | +7.7% | $472M | $1.54 | 2.7% | 8.7% |
| 2018 | $138M | -22.2% | $417M | $1.06 | 2.7% | 8.2% |
| 2017 | $177M | +53.5% | $356M | $0.87 | 4.0% | 8.0% |
| 2016 | $115M | -11.7% | $300M | $0.87 | 2.7% | 7.0% |
See SEM's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs SEM Undervalued?
See our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationCompare SEM vs AGIO
See how SEM stacks up against sector leader Agios Pharmaceuticals, Inc..
Start ComparisonFrequently Asked Questions
Is SEM growing earnings?
SEM EPS of $0.89 reflects slowing growth at -0.3%, below the 5-year CAGR of -9.7%. TTM net income is $110M. Expansion rate has moderated.
What are SEM's profit margins?
Select Medical Holdings Corporation net margin is +0.0%, with operating margin at +0.0%. Below-average margins reflect competitive or cost pressures.
How consistent are SEM's earnings?
SEM earnings data spans 2005-2025. The current earnings trend is -0.3% YoY. Historical data enables comparison across business cycles.